Skip to main content

Want a detailed portfolio tracker?

Alto Neuroscience (ANRO) P/E (2024 - 2026)

Alto Neuroscience (ANRO) P/E from Apr 1, 2024 to Jul 21, 2026. The TTM Alto Neuroscience (ANRO) P/E is -11.13. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Alto Neuroscience (ANRO)

YearP/EChange
2026-11.13+40.28%
2025-7.93+327.58%
2024-1.86N/A

Comparison Alto Neuroscience (ANRO) P/E with competitors

Alto Neuroscience (ANRO) P/E is -11.13.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.04%
ENLVEnlivex Ltd0.07-100.67%
FGENFibroGen Inc0.24-102.16%
CHRSCoherus Biosciences Inc0.85-107.62%
FBIOFortress Biotech Inc0.95-108.53%
ORMPOramed Pharmaceuticals Inc1.50-113.50%
AGENAgenus Inc3.01-127.04%
INVAInnoviva Inc3.15-128.33%
VXRTVaxart Inc3.55-131.89%
CRMDCorMedix Inc3.63-132.60%
CVACCureVac N.V.4.45-139.94%
GLPGGalapagos NV4.86-143.65%
SRPTSarepta Therapeutics Inc4.88-143.86%
ABEOAbeona Therapeutics Inc5.39-148.40%
ABUSArbutus Biopharma Corp5.60-150.27%
ZVRAZevra Therapeutics Inc5.89-152.89%
SPROSpero Therapeutics Inc6.23-155.95%
CGENCompugen Ltd6.31-156.72%
RIGLRigel Pharmaceuticals6.87-161.74%
SLXNSilexion Therapeutics Corp7.30-165.55%
OMEROmeros Corporation9.26-183.18%
AUPHAurinia Pharmaceuticals Inc9.58-186.11%
PLXProtalix BioTherapeutics Inc10.89-197.84%
ACADAcadia Pharmaceuticals Inc11.73-205.37%
TBPHTheravance Biopharma Inc12.26-210.16%
ADMAAdma Biologics Inc12.42-211.56%
HRMYHarmony Biosciences Holdings Inc13.82-224.16%
SABSSAB Biotherapeutics Inc14.14-227.00%
NAGENiagen Bioscience Inc14.82-233.12%
INCYIncyte Corp15.82-242.15%
REGNRegeneron Pharmaceuticals Inc15.86-242.45%
PBYIPuma Biotechnology Inc17.32-255.56%
CPRXCatalyst Pharmaceuticals Inc17.44-256.67%
EXELExelixis Inc17.54-257.56%
TGTXTG Therapeutics Inc18.97-270.39%
MDXGMimedx Group Inc20.55-284.64%
XOMAXOMA Royalty Corp22.87-305.51%
ARGXArgen X SE24.30-318.29%
CTMXCytomX Therapeutics Inc24.82-322.99%
XOMAOXOMA Royalty Corp25.34-327.70%
HALOHalozyme Therapeutics Inc25.62-330.20%
XOMAPXOMA Royalty Corp25.67-330.62%
VRTXVertex Pharmaceuticals Inc27.99-351.50%
RPRXRoyalty Pharma plc - Class A28.69-357.73%
SLNOSoleno Therapeutics Inc29.02-360.67%
ASNDAscendis Pharma A/S30.09-370.29%
LGNDLigand Pharmaceuticals Inc - Class B37.91-440.60%
APLSApellis Pharmaceuticals Inc39.02-450.57%
BMRNBiomarin Pharmaceutical Inc42.21-479.23%
KRYSKrystal Biotech Inc45.34-507.36%
ONCBeiGene Ltd69.54-724.75%
PHARPharming Group N.V.75.03-774.03%
TECHBio-Techne Corp101.96-1015.99%
VCELVericel Corp109.92-1087.53%
ALNYAlnylam Pharmaceuticals Inc117.96-1159.80%
GMABGenmab140.29-1360.37%
TLXTelix Pharmaceuticals Ltd162.15-1556.78%
CORTCorcept Therapeutics Inc212.86-2012.31%